摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-dibromo-4'-trifluoromethyl salicylanilide | 53607-05-9

中文名称
——
中文别名
——
英文名称
3,5-dibromo-4'-trifluoromethyl salicylanilide
英文别名
3,5-dibromo-2-hydroxy-N-[4-(trifluoromethyl)phenyl]benzamide
3,5-dibromo-4'-trifluoromethyl salicylanilide化学式
CAS
53607-05-9
化学式
C14H8Br2F3NO2
mdl
——
分子量
439.026
InChiKey
FLYZSJGIJYEAFV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    参考文献:
    名称:
    Identification and synthesis of low-molecular weight cholecystokinin B receptor (CCKBR) agonists as mediators of long-term synaptic potentiation
    摘要:
    Recently, He et al. reported that CCKB receptors located in the neocortex of the brain when bound to their bound natural ligand, CCK peptides, enhance memory, bringing up the possibility that agonists targeting the CCKB receptor may act as therapeutic agents in diseases in which memory loss is marked as observed in dementia and Alzheimer's. In this report, we describe the synthesis of novel low-molecular weight benzoamine CCKB receptor agonists. The compounds made in this series were determined to be mostly partial agonists, although some antagonists were identified, as well, capable of triggering calcium release in a cell line that overexpresses the CCKB receptor. Compound 35 demonstrated an EC50 of 0.15 mu M in the cell-based assay, but more importantly, several of the compounds, including 35, demonstrated a physiological effect, inducing long-term potentiation in rat brains comparable to the CCK-8 peptide albeit at much higher concentrations. Based on these findings, benzoamines may be the basis for a new series of CCKB receptor agonists in drug-discovery efforts that seek to develop therapeutics to prevent memory loss.
    DOI:
    10.1007/s00044-019-02292-x
点击查看最新优质反应信息

文献信息

  • ACTIVE DELIVERY SYSTEMS FORMULATIONS
    申请人:HOMOLA Andrew M.
    公开号:US20100040565A1
    公开(公告)日:2010-02-18
    The present invention relates to active delivery system formulations, and methods of making and using the same. Said formulations, when applied to a substrate surface, form a protective coating on the surface and permit constituent active agents to act on the surface and in the surrounding medium.
    本发明涉及活性传递系统配方,以及制备和使用这些配方的方法。当这些配方应用到基底表面时,在表面形成一层保护性涂层,并允许组分活性剂在表面和周围介质中起作用。
  • Antibacterial antiplaque mouthwash composition
    申请人:Colgate-Palmolive Company
    公开号:EP0579383A1
    公开(公告)日:1994-01-19
    An oral composition mouthwash or liquid dentifrice containing an aqueous vehicle acceptable vehicle including an alcohol, a substantially water-insoluble noncationic antibacterial antiplaque agent, such as 2,4,4'-trichloro-2'-hydroxy-diphenyl ether (triclosan) wherein the antiplaque agent is entirely dissolved in the solvent and the weight ratio of water to alcohol is in excess of about 10:1.
    一种口腔组合物漱口水或液体牙膏,含有可接受的水性载体,包括酒精、基本不溶于水的非阳离子抗菌消泡剂,如 2,4,4'-三氯-2'-羟基二苯醚(三氯生),其中消泡剂完全溶解在溶剂中,水与酒精的重量比超过约 10:1。
  • Oral composition containing salicylanilide antibacterial agent
    申请人:Colgate-Palmolive Company
    公开号:EP0628302A2
    公开(公告)日:1994-12-14
    An antiplaque oral composition such as a gel, paste or mouthrinse which is comprised of a vehicle having incorporated therein as the antiplaque agent an effective amount of an antibacterial salicylanilide compound and a surfactant mixture of an anionic surfactant, a polyoxyethylene/polyoxypropylene block copolymer and a taurate salt, the pH of the composition being adjusted to a pH of at least 8.0. An antibacterial-enhancing agent such as an anionic polymeric polycarboxylate which enhances the delivery of the salicylanilide compound to and retention on oral tissue surfaces is optionally incorporated in the composition to improve the efficacy of the salicylanilide compound.
    一种抗口腔污垢组合物,如凝胶、糊剂或漱口水,它由一种载体组成,载体中含有有效量的抗菌水杨酰苯胺化合物和一种阴离子表面活性剂、聚氧乙烯/聚氧丙烯嵌段共聚物和一种牛磺酸盐的表面活性剂混合物作为抗口腔污垢剂,组合物的 pH 值至少调节到 8.0。为提高水杨酰苯胺化合物的功效,可选择在组合物中加入抗菌增强剂,如阴离子聚合物聚羧酸盐,以增强水杨酰苯胺化合物向口腔组织表面的递送和在口腔组织表面的保留。
  • Oral compositions
    申请人:Colgate-Palmolive Company
    公开号:EP0692246A1
    公开(公告)日:1996-01-17
    Oral compositions comprising the combination of an effective surface tension reducing amount of an amphoteric surfactant and an effective antimicrobial amount of a blend of phenolic agents and a substantially water insoluble noncationic antibacterial agent, such as Triclosan, is disclosed. These compositions are indicated in the management or control of dental plaque.
    本发明公开了由有效降低表面张力的两性表面活性剂和有效抗菌量的酚类制剂混合物以及基本不溶于水的非阳离子抗菌剂(如三氯生)组合而成的口服组合物。这些组合物适用于控制牙菌斑。
  • Antimicrobial oral composition
    申请人:Colgate-Palmolive Company
    公开号:EP0696449A2
    公开(公告)日:1996-02-14
    A oral composition which inhibits plaque formation and reduces gingivitis and caries comprising a substantially water insoluble noncationic antimicrobial agent, such as triclosan and an acid reducing agent, such as xylitol. The composition is a dentifrice containing a siliceous polishing agent.
    一种可抑制牙菌斑形成、减少牙龈炎和龋齿的口腔组合物,包含一种基本不溶于水的非阳离子抗菌剂(如三氯生)和一种酸还原剂(如木糖醇)。该组合物是一种含有硅抛光剂的牙膏。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐